ELMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 122.3% based on the discounted cash flow analysis.
| Market cap | $320.27 Million |
|---|---|
| Enterprise Value | $303.29 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.9 |
| Beta | 0.52 |
| Outstanding Shares | 8,211,220 |
| P/E Ratio | 31.7 |
|---|---|
| PEG | 53.92 |
| Price to Sales | 4.89 |
| Price to Book Ratio | 7.82 |
| Enterprise Value to Revenue | 4.23 |
| Enterprise Value to EBIT | 22.92 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 20,500▼ 30.03% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 53.56%▼ 0.79% |
|---|---|
| Total Invested | $103.73M▼ 20.68% |
| Investors Holding | 1030% |
No data
Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992.